Clear Filters

News Listing

Uncategorized

In an op-ed, USC’s Dana Goldman argues that a revived federal Office of Technology Assessment could provide a sharp focus on medical innovation and advise lawmakers on appropriating pricing for new technologies.

Jun 17, 2019